Patent ID: 11970496
Assignee: KING FAISAL UNIVERSITY
Field: Pharmaceuticals (Chemistry)
Classification: CPC C  A | IPC A  C

Claim 1:
2. A method of treating a cancer in a patient, comprising administering to a patient in need thereof a therapeutically effective amount of a compound having the formula I:, , or a pharmaceutically acceptable salt, stereoisomer, or solvate thereof, wherein:
R1, R2, and R4 are all hydrogen;
R3 is —NHAr and Ar is phenyl substituted with one or more substituents independently selected from the group consisting of —NR5R6, a straight or branched C1-C6 alkyl, —OR5, —SO2NR5R6, and halogen, wherein R5 and R6 are independently a straight chain C1-C6 alkyl group; a —NHCH2CH2CH2NR7R8 group; a —NHCH2phenyl group substituted with a chlorine; and a (2-methylpyridin-4-yl)amino group; and
R7 and R8 are independently a straight chain C1-C6 alkyl group,
wherein the cancer is one or more selected from the group consisting of leukemia, melanoma, colon cancer, prostate cancer, pancreatic cancer, and breast cancer.